DRAK2 Antikörper (AA 235-366)
-
- Target Alle DRAK2 (STK17B) Antikörper anzeigen
- DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
-
Bindungsspezifität
- AA 235-366
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser DRAK2 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Western Blotting (WB), Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human, Maus
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Serine/threonine-protein kinase 17B protein (235-366AA)
- Isotyp
- IgG
- Top Product
- Discover our top product STK17B Primärantikörper
-
anti-serine/threonine Kinase 17b (STK17B) (AA 272-372) antibody
STK17B Reaktivität: Human ELISA, WB, IF, IHC (p) Wirt: Maus Monoclonal 2C3 unconjugated
anti-serine/threonine Kinase 17b (STK17B) (AA 342-371), (C-Term) antibodySTK17B Reaktivität: Human, Maus WB, IF, IHC (p) Wirt: Kaninchen Polyclonal RB3049 unconjugated
anti-serine/threonine Kinase 17b (STK17B) (Internal Region) antibodySTK17B Reaktivität: Human, Maus, Ratte ELISA, WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) antibodySTK17B Reaktivität: Human, Maus, Ratte ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (AA 1-372) antibodySTK17B Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (C-Term) antibodySTK17B Reaktivität: Human, Maus, Ratte ELISA, WB, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (Internal Region) antibodyVerified STK17B Reaktivität: Human ELISA, WB Wirt: Ziege Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (Center) antibodySTK17B Reaktivität: Human, Maus, Ratte, Rind (Kuh) WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (C-Term) antibodySTK17B Reaktivität: Human WB, IF, EIA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Recommended dilution: WB:1:500-1:5000, IHC:1:200-1:500,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
- Andere Bezeichnung
- STK17B (STK17B Produkte)
- Synonyme
- zgc:65989 antikoerper, STK17B antikoerper, DRAK2 antikoerper, Drak2 antikoerper, 3110009A03Rik antikoerper, AI120141 antikoerper, serine/threonine kinase 17b (apoptosis-inducing) antikoerper, serine/threonine kinase 17b antikoerper, stk17b antikoerper, STK17B antikoerper, Stk17b antikoerper
- Hintergrund
-
Background: Phosphorylates myosin light chains. Acts as a positive regulator of apoptosis.
Aliases: DAP kinase related apoptosis inducing protein antibody, DAP kinase related apoptosis inducing protein kinase 2 antibody, DAP kinase-related apoptosis-inducing protein kinase 2 antibody, Death associated protein kinase related 2 antibody, DRAK 2 antibody, DRAK2 antibody, Serine/threonine kinase 17b antibody, Serine/threonine kinase 17b apoptosis inducing antibody, Serine/threonine protein kinase 17B antibody, Serine/threonine-protein kinase 17B antibody, ST17B_HUMAN antibody, STK 17B antibody, Stk17b antibody
- UniProt
- O94768
-
